SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-055866
Filing Date
2006-03-16
Accepted
2006-03-16 08:54:53
Documents
10
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 CORTEX PHARMACEUTICALS 10-K RE FYE 2005 d10k.htm 10-K 869080
2 CERTIFICATE OF AMENDMENT OF RESTATED CERT. OF INCORPORATION FILED 3/2/2006 dex34.htm EX-3.4 7731
3 EMPLOYMENT LETTER DATED JANUARY 9, 2006 WITH MARK VARNEY, PH.D. dex1092.htm EX-10.92 21623
4 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 1032
5 CONSENT OF ERNST & YOUNG, LLP dex231.htm EX-23.1 1941
6 CONSENT OF HASKELL & WHITE LLP dex232.htm EX-23.2 1958
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 9074
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 9070
9 CERTIFICATION PURSUANT TO SECTION 906 dex32.htm EX-32 4281
10 GRAPHIC g86598img001.jpg GRAPHIC 21150
  Complete submission text file 0001193125-06-055866.txt   956465
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-16467 | Film No.: 06690051
SIC: 2834 Pharmaceutical Preparations